Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy
Authors:
- Elaine ScottESElaine Scott
- The North Star Clinical Network For Paediatric Neuromuscular DiseaseTDThe North Star Clinical Network For Paediatric Neuromuscular Disease
- 23 September 2011
- journal article
- research article
- Published by Wiley in Physiotherapy Research International
- Vol. 17 (2) , 101-109
Abstract
Background and Purpose: The aims of this study were to develop a clinical assessment scale to measure functional ability in ambulant boys with Duchenne muscular dystrophy and to determine the reliability of the scale in multiple centres in the UK.Methods: Focus groups and workshops were held with experienced paediatric neuromuscular physiotherapists to determine scale content. A manual was prepared with accompanying videos, and training sessions were conducted. A total of 17 physiotherapists from participating centres used the videos to determine inter‐rater reliability. Five determined the intra‐rater reliability.Results: Strength of agreement for these groups based on total subject scores was very good (0.95 and ≥0.93 for consistency and absolute agreement, respectively). Test–retest ability was high, with perfect agreement between occasions for all but two items of the scale.Conclusions: Our study indicates that the North Star Ambulatory Assessment is practical and reliable. It takes only 10 minutes to perform and incorporates both universally used timed tests as well as levels of activities, which allow assessment of high‐functioning boys with Duchenne muscular dystrophy. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyThe Lancet Neurology, 2009
- Update on the management of Duchenne muscular dystrophyArchives of Disease in Childhood, 2008
- Glucocorticoid corticosteroids for Duchenne muscular dystrophy2008
- Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment toolDevelopmental Medicine & Child Neurology, 2007
- La mesure de fonction motrice, outil d’évaluation clinique des maladies neuromusculaires. Étude de validationRevue Neurologique, 2006
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Physical Activity, Health Impairments, and Disability in Neuromuscular DiseaseAmerican Journal of Physical Medicine & Rehabilitation, 2002
- Physical capacity in non‐ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal studyDevelopmental Medicine & Child Neurology, 2002
- Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophyMuscle & Nerve, 1982
- The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of ReliabilityEducational and Psychological Measurement, 1973